Indiana-based Endo Pharmaceuticals is the first of potentially many pharmaceutical manufacturers to receive pressure from the Food and Drug Administration (FDA) to remove a powerful opioid from the market.
FDA Commissioner Dr. Scott Gottlieb voiced his concern about the public wellbeing: “We are facing an opioid epidemic — a public health crisis — and we must take all necessary steps to reduce the scope of opioid misuse and abuse,”
Powerful Painkiller Opana ER linked to “the public health consequences of abuse.”
CNN reported on the issue, citing the Opana ER’s history of drug abuse. During the 2015 HIV outbreak in Indiana, Opana ER was the preferential drug for many addicts.
Dr. Andrew Kolodny, co-director of opioid policy research at the Heller School for Social Policy and Management at Brandeis University also weighed in on the issue. “Opana is not the only one that needs to come off the market.” Hopefully, in time the FDA will work with drug manufacturers to take meaningful steps to prevent habitual opioid abuse.
Are You A love On Struggling With Addiction? Personalized substance abuse care is available 24/7 at our state-of-the-art clinic. Call 866-421-6242 to speak with one of our qualified addiction counselors or Click Here To Learn More Today!
Read the full story at CNN.com.